Posted on November 30, 202011/30/20
MacroGenics and EVERSANA Announce Agreement to Support the Potential Launch and Commercialization of Margetuximab
Posted on November 30, 202011/30/20
Informa Connect’s Trade and Channel Strategies 2020
Posted on November 30, 202011/30/20
Moderna Seeks FDA, EMA Authorization Following mRNA-1273 Analysis Showing Vaccine 94.1% Effective
Posted on November 30, 202011/30/20
MacroGenics and EVERSANA announce deal for Margetuximab
Posted on November 23, 202011/23/20
President Trump Unveils Rules to Lower U.S. Prescription Drug Prices
Posted on November 19, 202011/19/20
HTA and Market Access: An International Perspective From CAHR MA 201
Posted on November 19, 202011/19/20
EVERSANA and Healthjump Partner to Deepen Integration of Predictive Patient Services and Enhance RWD-based Patient Outcomes
Posted on November 19, 202011/19/20
EVERSANA and Healthjump partner to deepen integration of predictive patient services and enhance RWD-based patient outcomes
Posted on November 18, 202011/18/20
BPI Backs Installment Payments, Returning Funds to Health Insurers’ Morbi-RSA Funding Pool
Posted on November 18, 202011/18/20